| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647640 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 20 Pages |
Abstract
C-OCS use was associated with more asthma burden, comorbidities, and greater blood eosinophil counts. Prior C-OCS use was the strongest predictor of future C-OCS use.
Keywords
OCsICSSABAHEDISPersistent asthmaAllergistShort-acting β2-agonistShort-acting β2-agonistsemergency departmentExacerbationsAdministrative dataasthma guidelinesGlobal Initiative for AsthmaHealthcare Effectiveness Data and Information SetManaged careRisk ratioComorbiditiesAsthma controloral corticosteroidCorticosteroidInhaled corticosteroidGINA
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Robert S. MD, PhD, Michael MD, MS, Qiaowu MS, Wansu MS, PhD, Deepak B. MS, MA, PhD, Trung N. MD, PhD,